Nantahala Capital Management LLC 13D and 13G filings for Evoke Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-03 4:47 pm Purchase | 2025-02-03 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management LLC | 254,639 15.990% | 7 (+0.00%) | Filing |
| 2024-11-06 4:31 pm Purchase | 2024-11-06 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management LLC | 254,632 15.990% | 169,946 (+200.68%) | Filing |
| 2024-10-01 4:53 pm Unchanged | 2024-09-27 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management LLC | 84,686 10.000% | 0 (Unchanged) | Filing |
| 2024-09-20 7:28 pm Purchase | 2024-09-20 | 13D | Evoke Pharma, Inc. EVOK | Nantahala Capital Management LLC | 84,686 10.000% | 84,686 (New Position) | Filing |